Cargando…

Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) is an emerging extended modality of diffusion-weighted imaging for screening malignant lesions in the body. A 70-year-old male was diagnosed with advanced-stage prostate adenocarcinoma with distant metastasis. Afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Katano, Atsuto, Takeuchi, Kenta, Yamashita, Hideomi, Nakagawa, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001865/
https://www.ncbi.nlm.nih.gov/pubmed/35464507
http://dx.doi.org/10.7759/cureus.23047
_version_ 1784685764946165760
author Katano, Atsuto
Takeuchi, Kenta
Yamashita, Hideomi
Nakagawa, Keiichi
author_facet Katano, Atsuto
Takeuchi, Kenta
Yamashita, Hideomi
Nakagawa, Keiichi
author_sort Katano, Atsuto
collection PubMed
description Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) is an emerging extended modality of diffusion-weighted imaging for screening malignant lesions in the body. A 70-year-old male was diagnosed with advanced-stage prostate adenocarcinoma with distant metastasis. After hormone therapy, the disease progressed to castration-resistant prostate cancer (CRPC). Serum prostate-specific antigen (PSA) levels increased during androgen deprivation therapy with low serum testosterone levels. 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) and technetium-99m methylene bone scintigraphy (BS) did not reveal obvious distant metastases; however, we were able to identify distant metastases by DWIBS. We herein report a case in which stereotactic body radiotherapy (SBRT) was performed on target lesions detected by DWIBS and successfully suppressed disease progression.
format Online
Article
Text
id pubmed-9001865
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90018652022-04-23 Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer Katano, Atsuto Takeuchi, Kenta Yamashita, Hideomi Nakagawa, Keiichi Cureus Radiation Oncology Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) is an emerging extended modality of diffusion-weighted imaging for screening malignant lesions in the body. A 70-year-old male was diagnosed with advanced-stage prostate adenocarcinoma with distant metastasis. After hormone therapy, the disease progressed to castration-resistant prostate cancer (CRPC). Serum prostate-specific antigen (PSA) levels increased during androgen deprivation therapy with low serum testosterone levels. 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) and technetium-99m methylene bone scintigraphy (BS) did not reveal obvious distant metastases; however, we were able to identify distant metastases by DWIBS. We herein report a case in which stereotactic body radiotherapy (SBRT) was performed on target lesions detected by DWIBS and successfully suppressed disease progression. Cureus 2022-03-10 /pmc/articles/PMC9001865/ /pubmed/35464507 http://dx.doi.org/10.7759/cureus.23047 Text en Copyright © 2022, Katano et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Katano, Atsuto
Takeuchi, Kenta
Yamashita, Hideomi
Nakagawa, Keiichi
Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
title Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
title_full Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
title_fullStr Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
title_full_unstemmed Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
title_short Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
title_sort stereotactic body radiotherapy for a sacral metastasis clarified by diffusion-weighted whole-body imaging with background body signal suppression in a patient with castration-resistant prostate cancer
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001865/
https://www.ncbi.nlm.nih.gov/pubmed/35464507
http://dx.doi.org/10.7759/cureus.23047
work_keys_str_mv AT katanoatsuto stereotacticbodyradiotherapyforasacralmetastasisclarifiedbydiffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressioninapatientwithcastrationresistantprostatecancer
AT takeuchikenta stereotacticbodyradiotherapyforasacralmetastasisclarifiedbydiffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressioninapatientwithcastrationresistantprostatecancer
AT yamashitahideomi stereotacticbodyradiotherapyforasacralmetastasisclarifiedbydiffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressioninapatientwithcastrationresistantprostatecancer
AT nakagawakeiichi stereotacticbodyradiotherapyforasacralmetastasisclarifiedbydiffusionweightedwholebodyimagingwithbackgroundbodysignalsuppressioninapatientwithcastrationresistantprostatecancer